Lacosamide is a DEA Schedule V controlled substance. Substances in the DEA Schedule V have a low potential for abuse relative to substances listed in Schedule IV and consist mainly of preparations containing limited quantities of certain narcotics. It is a Depressants substance. It is grouped under the following drug class(es): Neurotransmitter agents and Schedule V controlled substances. Its therapeutic use is listed as anti-epileptic drugs, anticonvulsants and central nervous system (CNS) agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Vimpat and Harkoseride. It is listed as a controlled drug substance (Schedule V). Its PubChem CID is 219078.
Lacosamide
| CAS No | 175481-36-4 |
|---|---|
| Molecular Formula | C13H18N2O3 |
| Molecular Weight | 250.29 g/mol |
| Synonyms | (2R)-2-acetamido-N-benzyl-3-methoxypropanamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Lacosamide is a DEA Schedule V controlled substance. Substances in the DEA Schedule V have a low potential for abuse relative to substances listed in Schedule IV and consist mainly of preparations containing limited quantities of certain narcotics.
The listed CAS number is 175481-36-4.
The listed molecular formula is C13H18N2O3.
The listed molecular weight is 250.29 g/mol.
(2R)-2-acetamido-N-benzyl-3-methoxypropanamide.
The source lists Vimpat and Harkoseride.